Lotus Pharmaceutical Co., Ltd. (TPE:1795)
Taiwan · Delayed Price · Currency is TWD 287.00
-1.00 (-0.35%)
Nov 13, 2025, 2:38 PM CST
Lotus Pharmaceutical Market Cap
Lotus Pharmaceutical has a market cap or net worth of 75.74 billion as of November 12, 2025. Its market cap has increased by 9.84% in one year.
Market Cap
75.74B
Enterprise Value
83.24B
Revenue
19.12B
Ranking
n/a
PE Ratio
15.58
Stock Price
287.00
Market Cap Chart
Since August 12, 2014, Lotus Pharmaceutical's market cap has increased from 9.19B to 75.74B, an increase of 724.37%. That is a compound annual growth rate of 20.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2025 | 75.74B | 5.89% |
| Dec 31, 2024 | 71.52B | -0.57% |
| Dec 29, 2023 | 71.94B | 11.59% |
| Dec 30, 2022 | 64.46B | 152.11% |
| Dec 30, 2021 | 25.57B | 30.27% |
| Dec 31, 2020 | 19.63B | -29.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 194.65B |
| PharmaEssentia | 164.97B |
| Bora Pharmaceuticals Co., LTD. | 75.59B |
| Lumosa Therapeutics | 31.50B |
| Oneness Biotech | 29.08B |
| Pegavision | 26.48B |
| Center Laboratories | 26.24B |
| Lin BioScience | 23.91B |